These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 4978901)

  • 1. [Study on the extrapyramidal system from the standpoint of pharmacology and psychopharmacology].
    Hara S
    Zasshi Tokyo Ika Daigaku; 1969 Jan; 27(1):1-22. PubMed ID: 4978901
    [No Abstract]   [Full Text] [Related]  

  • 2. [Possibilities of detecting and differentiating central nervous effects of drugs in animal experiments with special consideration of behavioral-pharmacologic methods].
    Hoffmeister F; Wuttke W
    Arzneimittelforschung; 1975 Jul; 25(7a):1162-78. PubMed ID: 241358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations for the pre-clinical evaluation of new psychiatric drugs: a case study with phenothiazine-like tranquilizers.
    Irwin S
    Psychopharmacologia; 1966; 9(4):259-87. PubMed ID: 6011791
    [No Abstract]   [Full Text] [Related]  

  • 4. [Extrapyramidal symptoms during the use of neuroleptics].
    Ditfurth HV
    Nervenarzt; 1967 Apr; 38(4):151-5. PubMed ID: 4382350
    [No Abstract]   [Full Text] [Related]  

  • 5. [Extrapyramidal complications of psychopharmacological drugs].
    Vacek J
    Cesk Psychiatr; 1969 Dec; 65(6):414-21. PubMed ID: 4983105
    [No Abstract]   [Full Text] [Related]  

  • 6. [The antipsychotic action of neuroleptics and basal ganglia function].
    Arushanian EB
    Farmakol Toksikol; 1973; 26(4):481-9. PubMed ID: 4151298
    [No Abstract]   [Full Text] [Related]  

  • 7. [The drug-induced Parkinson's syndrome].
    Pakesch E
    Wien Z Nervenheilkd Grenzgeb; 1966; 23(1):140-6. PubMed ID: 4226879
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological studies with some newly synthesized phenothiazines exhibiting lesser extrapyramidal reactions.
    Sharma VN; Mital RL; Banerjee SP; Sharma HL
    Jpn J Pharmacol; 1969 Jun; 19(2):211-23. PubMed ID: 5308826
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of amphetamine induced stereotyped behaviour as a model for the experimental evaluation of antiparkinson agents.
    Costall B; Naylor RJ; Wright T
    Arzneimittelforschung; 1972 Jul; 22(7):1178-83. PubMed ID: 4404343
    [No Abstract]   [Full Text] [Related]  

  • 10. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R
    Med Klin; 1969 Aug; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the mode of action and the question of central organic late damages of continuous neuroleptic treatment].
    Haddenbrock S
    Nervenarzt; 1966 May; 37(5):199-203. PubMed ID: 5298253
    [No Abstract]   [Full Text] [Related]  

  • 12. Neutralization of extrapyramidal side-effects with Methixene.
    Maller O; Heller S
    Dis Nerv Syst; 1971 Jun; 32(6):409-15. PubMed ID: 5570695
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacology of medazepam and metabolites.
    Randall LO; Scheckel CL; Pool W
    Arch Int Pharmacodyn Ther; 1970 May; 185(1):135-48. PubMed ID: 4248485
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-induced extrapyramidal symptoms and their relations to clinical efficacy.
    Chien CP; Dimascio A
    Am J Psychiatry; 1967 Jun; 123(12):1490-8. PubMed ID: 5337751
    [No Abstract]   [Full Text] [Related]  

  • 15. [L-DOPA jumping test in mice: its use in the study of antagonistic psychotropic drugs].
    Gouret C; Raynaud G
    C R Seances Soc Biol Fil; 1973; 167(10):1360-6. PubMed ID: 4799982
    [No Abstract]   [Full Text] [Related]  

  • 16. The neuroleptics. 3. Pharmacology. Introduction.
    Van Rossum JM; Janssen PA; Boissier JR; Julou L; Loew DM; Moller Nielsen I; Munkvad I; Randrup A; Stille G; Tedeschi DH
    Mod Probl Pharmacopsychiatry; 1970; 5():23-32. PubMed ID: 5527165
    [No Abstract]   [Full Text] [Related]  

  • 17. [Longitudinal profiles of the effects of psychotropic drugs. Animal experimental findings].
    Kreiskott H
    Arzneimittelforschung; 1974 Jul; 24(7):974-6. PubMed ID: 4408071
    [No Abstract]   [Full Text] [Related]  

  • 18. The pharmacology of fluspirilene (R 6218), a potent, long-acting and injectable neuroleptic drug.
    Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM; Verbruggen FJ; van Nueten JM; Marsboom RH; Hérin VV; Schaper WK
    Arzneimittelforschung; 1970 Nov; 20(11):1689-98. PubMed ID: 4992598
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug induced functional disorders of the tongue, pharynx and larynx].
    Bauer H
    Z Laryngol Rhinol Otol; 1967 Mar; 46(3):154-9. PubMed ID: 4870673
    [No Abstract]   [Full Text] [Related]  

  • 20. On the interaction between neuroleptics and antiparkinson drugs.
    Julou L
    Mod Probl Pharmacopsychiatry; 1970; 5():50-4. PubMed ID: 5527168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.